Results 1 to 10 of about 1,881 (168)

Adverse event of ACE inhibitors: A descriptive analysis of FAERS data [PDF]

Journal of Public Health Research
Background and objective: Angiotensin-converting enzyme inhibitors are first-line therapies for hypertension and related cardiovascular and renal conditions. The study aimed to characterize the adverse event profile of ACE inhibitors using the U.S.
Nehad Jaser Ahmed
doaj   +2 more sources

Safety of Drugs in Breastfeeding Women With CKD [PDF]

Kidney International Reports
Introduction: The benefits of breastfeeding are widely recognized. Because of lack of evidence, women may forego breastfeeding or decline treatments that impact long-term renal survival.
Paula Parnizari, Michelle A. Hladunewich, Jonathan Zipursky   +2 more
doaj   +2 more sources

Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity

Scientific Reports, 2021
Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described.
Majid Jaberi-Douraki, Emma Meyer, Jim Riviere, Nuwan Indika Millagaha Gedara, Jessica Kawakami, Gerald J. Wyckoff, Xuan Xu   +6 more
doaj   +1 more source

INFLUENCE OF QUINAPRIL ON THE REGULATORY-ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE HYHA CLASS I: RESULTS OF NOT COMPARATIVE STUDY

Рациональная фармакотерапия в кардиологии, 2015
Aim. To assess effects of quinapril on the regulatory-adaptive status (RAS) in patients with chronic heart failure (CHF) NYHA class 1 and arterial hypertension (HT). Material and methods.
V. G. Tregubov, S. G. Kanorskiy, V. M. Pokrovskiy   +2 more
doaj   +3 more sources

Thin-layer chromatography of several antihypertensive drugs from the group of angiotensin converting enzyme inhibitors [PDF]

Journal of the Serbian Chemical Society, 2001
Arapid and simple method for the chromatographic separation of pharmacologically active components contained in some antihypertensive drugs has been developed employing thin-layers of silica gel and polyacrylonitrile sorbent (PANS).
Aleksić Mirjana B., Agbaba Danica G., Baošić Rada M., Milojković-Opsenica Dušanka M., Tešić Živoslav Lj.   +4 more
doaj   +3 more sources

Organo-protective effects of quinapril: pharmacogenetic aspects

Кардиоваскулярная терапия и профилактика, 2011
The review presents current experimental and clinical evidence on organo-protective effects of an ACE inhibitor quinapril. These effects are dependent on I/D polymorphism of ACE gene.
D. A. Sychev, O. V. Muslimova
doaj   +1 more source

Influence of bisoprolol and nebivolol on the regulatory-adaptive status of patients with diastolic chronic heart failure [PDF]

КардиоСоматика, 2022
Background. Chronic heart failure (CHF) is the most common outcome of cardiovascular disease, of hypertension disease (HD). Beta-blockers contribute to the correction of hypertension, reduce heart remodeling, slow the progression of CHF. At the same time,
Pavel V. Khilkevich, Vitalii G. Tregubov, Iosif Z. Shubitidze, Anna V. Tregubova   +3 more
doaj   +1 more source

Interventions to Decrease Carotid-Intima Media Thickness in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-Analysis

Frontiers in Clinical Diabetes and Healthcare, 2022
IntroductionHyperglycemia is associated with a higher cardiovascular risk, as evidenced by increased carotid-intima media thickness (CIMT) in youth with diabetes.
Adina Mihaela Epure, Adina Mihaela Epure, Daniela Anker, Stefano Di Bernardo, Bruno R. da Costa, Bruno R. da Costa, Nicole Sekarski, Arnaud Chiolero, Arnaud Chiolero, Arnaud Chiolero, Arnaud Chiolero   +10 more
doaj   +1 more source

Assessment of the effect of nebivolol and сarvedilol on the functional state of patients with diastolic chronic heart failure

КардиоСоматика, 2021
Aim. To determine the effect of combined therapy with nebivolol or carvedilol on the functional state of patients with diastolic chronic heart failure (CHF). Material and methods.
Vitalii G. Tregubov, Pavel V. Khil′kevich, Iosif Z. Shubitidze, Anna V. Tregubova   +3 more
doaj   +1 more source

Zebrafish drug screening identifies candidate therapies for neuroprotection after spontaneous intracerebral haemorrhage

Disease Models & Mechanisms, 2022
Despite the global health burden, treatment of spontaneous intracerebral haemorrhage (ICH) is largely supportive, and translation of specific medical therapies has not been successful.
Siobhan Crilly, Adrian Parry-Jones, Xia Wang, Julian N. Selley, James Cook, Victor S. Tapia, Craig S. Anderson, Stuart M. Allan, Paul R. Kasher   +8 more
doaj   +1 more source